Polish Nationwide Registry of Diagnostics, Treatment and Outcome in Patients With Cardiogenic Shock

NCT06697093 · tracked via the Priya Life Science Poland tracker

Sponsor

Wroclaw Medical University

Phase

Observational

Started

2025-04-01

Last updated

2025-04-02

Condition(s) studied

Cardiogenic Shock

Study summary

The registry objective is to get information on current epidemiology, diagnostics, treatment and outcome in patients with cardiogenic shock in Poland. Obtained information will help to plan the nationwide initiative for modern cardiogenic shock treatment with established place for mechanical circulatory support.

It is hypothesized that the treatment and outcome of cardiogenic shock, including mechanical circulatory support, are currently poor in Poland and should be improved. Unfortunately, without status quo data, efficient planning for its improvement cannot be conducted, hence the CaS-POL registry initiative.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Cardiogenic shock patients of all etiologies in SCAI stage B, C, D, E. * age \> 18 years old * persistent hemodynamic failure defined as systolic blood pressure of \<90 mmHg for ≥ 30 minutes or the requirement for inotropic or vasopressor agents with evidence of hypoperfusion of the peripheral organs Exclusion Criteria: * patients without return of spontaneous circulation who were considered to extracorporeal cardiopulmonary resuscitation (ECPR) * primary septic, anaphylactic, hypovolemic shock * post-operative cardiogenic shock * end-stage of heart failure disqualified from mechanical circulatory support and heart transplantation

Primary outcome measure(s)

all-cause mortality — From the date of cardiogenic shock diagnosis recognition until the date of death from any cause assessed up to 6 months
all-cause mortality

Trial sites (2)

Facility	City	Region	Status
Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland	Wroclaw	Lower Silesian Voivodeship	Not Yet Recruiting
Wroclaw Medical University	Wroclaw	Poland	Recruiting

More Wroclaw Medical University trials in Poland

The Impact of Expandable Cryoballoon on Autonomic Control of the Heart Active, not recruiting

Effectiveness of iPRF Injections in Temporomandibular Joints Degeneration Management Enrolling by invitation

Selected Disorders and Sleep Bruxism Enrolling by invitation

Concentration of Receptors With Affinity for Cannabidiol and Cannabinol and the Effect on Chronic Orofacial Pain of Muscle Origin Enrolling by invitation

Evaluation of the Factors Associated With BRADYcardia Following Pulmonary Vein Isolation Using Pulsed Field Ablation Recruiting

Other trials for the same condition

Lower Silesia Cardiogenic Shock Initiative Recruiting

A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06697093 on ClinicalTrials.gov ↗ ← All trials in Poland